Los Angeles, CA
Joined December 2012
Gregg Fonarow MD retweeted
💰 The broader annual cost burden of Heart Failure (HF) is projected to reach $858 billion by 2050. Yet, we hold an extraordinarily cost-effective solution in our hands today. See below for more + click here for more insights from our HF STATS 2026 report bit.ly/3ULm2vS
1
2
1
2
322
💊Is evolocumab cost-effective before a first MI or stroke? 
📊 VESALIUS-CV lifetime model at $3,107/yr 
❤️ −0.24 MACE/person 
✅ ICER $71,162/QALY; scenarios $20K–$51K 
🎯 All below the $120K AHA/ACC threshold 
⚠️ Preprint 
🔗 doi.org/10.64898/2026.07.23.…
1
4
23
2,135
💊 PCSK9 inhibitors in the US, Oct 2026: 
💉 Repatha: ~60%↓LDL | CVOT ✅ | $239/mo 
💉 Praluent: ~45–60% | CVOT ✅ | $225/mo 
🩺 Leqvio: ~50% | CVOT ⏳ | no DTC 
💉 Lerochol: ~56–60% | CVOT ❌ | $199/mo 
💊 Lipfendra (oral!): ~56–59% | CVOT ⏳ | $315 list 
 #Lipids
8
23
2
125
12,945
Trial after trial, vitamin D supplements keep coming up empty: 💊 VITAL (25,871): no CV benefit 
🧬 83,000 across 21 RCTs: null 
💀 80 RCTs: no CV benefit 
🩺 SIMPLIFIED (2026, dialysis): no ☠️ benefit, HR 0.94 Billions spent on RCTs Still nothing Low D is a marker
5
3
1
23
1,407
Gregg Fonarow MD retweeted
👏 Congratulations go out to Amrut Ambardekar, MD, FHFSA of the University of Colorado Health for being named this year's Distinguished HFSA Service Award winner at #HFSA2026 Learn more 👉 youtube.com/watch?v=T_AGfOX4…
1
1
14
652
Gregg Fonarow MD retweeted
CMS's 2027 HF model has no measure for MRAs or SGLT2i, and doesn't require ARNI. Modeled: every eligible U.S. HFrEF patient on all 3 at generic prices (~$227/yr) could prevent ~87.5K deaths and save ~$14.1B net per year. Keykhaei et al, JACC HF 2026
#HFrEF #Cardiology
1
4
20
782
💊 Does stopping cardiovascular meds make patients feel better? 
🔬 6 deprescribing RCTs, 3,748 older/frail patients 
😐 QoL better in just 1 of 5 
⚠️ Adverse events reduced: 0 of 6 
⚖️ Death/hospitalization better: 0 of 6 
🚫 Rarely helpful 😳 
#Deprescribing
3
8
1
19
1,930
🫀 Quadruple guideline-directed medical therapy (GDMT) offers a profound mortality benefit, yet it remains severely underutilized across Heart Failure (HF) care today. Data from HF STATS 2026 reveals only 18% of patients with HFrEF receive all 4 foundational medication pillars.
3
8
15
808
Gregg Fonarow MD retweeted
🌟🏅Congratulations to the winner of this year's HFSA Distinguished Mentor Award, Lynne Stevenson, MD of Vanderbilt University Health, for her leadership and mentorship in the #HeartFailure field! #HFSA2026 Stay tuned for more award announcements! Learn more about Lynne Stevenson, MD here 👉 youtube.com/watch?v=sUci1Cgi…
3
14
668
❓for @CMSGov Why does the 2027 HF ASM measure beta-blockers and RASi 💊 but not ARNI, MRA or SGLT2i? Those 3 could prevent: ~88K deaths 💔 a year ~746K 🏥 a year Saving $14.1B 💰, at $227/yr per patient What are we missing? 🤷 @ACCinTouch @American_Heart @HFSA @AAHFN
5
2
21
834
Gregg Fonarow MD retweeted
Heart failure care has advanced, but the US burden continues to grow. A new report shows mortality is rising as more Americans are being affected, with obesity, diabetes, and other comorbidities potentially contributing to the trend. #HeartFailure #PublicHealth bit.ly/4rZGy8a
1
3
9
1,010
🚨 @CMSgov's 2027 HF Ambulatory Specialty Model leaves out ARNI, MRA & SGLT2i 🤯 Adding optimally each year: 💔 87,537 deaths prevented 🏥 746,196 hospitalizations avoided 💰 $14.1B net savings 💊 All 3 generic: $18.90/mo on Cost Plus Drugs Fix it now! #HFrEF #GDMT @HFSA
2
2
14
675
🫀 Ready to make a difference in #HCM care? The @American_Heart Hypertrophic Cardiomyopathy Registry is enrolling! 📊 National HCM registry
🏆 Hospital QI recognition
📜 Hospital & pro certification
🩺 Patient support
🤖 AI detection pilot 
👉 heart.org/hcmregistry
1
3
16
861
🚑 ICH patients reach the ED faster than those with ischemic stroke (median 127 vs 175 min from last known well) 🧠 But once stroke severity is accounted for, they're LESS likely to meet ED care targets ⏱️ Time is brain for ICH too 📄 Royan et al, doi.org/10.1001/jamanetworko…
1
4
8
519
💊 Starting HFrEF GDMT: 8 landmark RCTs, 30,523 pts, ~55,600 patient-yrs, 6,725 deaths/HF events 
🛑 Stopping GDMT after EF recovery: 5 pilot RCTs, 313 pts, ~300 patient-yrs, surrogates only 
⚖️ ~180× less follow-up 
📕 Keep GDMT going until real RCTs say otherwise
2
5
17
965
Gregg Fonarow MD retweeted
GDMT is Associated with Reduced Loop Diuretic Requirements, Whereas Diuretic Dose Does Not Modify GDMT Benefit in Heart Failure: STRONG-HF. GDMT optimization acted as diuretic-sparing therapy: reaching target doses, particularly of all three classes, was associated with markedly lower LD requirement. @hfcollaboratory @gcfmd @SJGreene_md @mvaduganathan academic.oup.com/eurjhf/adva…
1
4
23
776
🧠 New in @JAMANetworkOpen: ICH vs ischemic stroke in 195,659 EMS arrivals GWTG-Stroke, 2015–24 🚑 ICH patients arrive at the ED faster 
⏱️ But once adjusting for stroke severity, they're LESS likely to hit ED targets (MD ≤10 min, imaging ≤20 min) Time is brain for ICH too!
1
4
489
🫀📡 New in JACC: Heart Failure: AI-guided monitoring after HF discharge was feasible, but didn't cut re-🏨 or ED visits/readmission/death 🏥 5 VA centers | 🩹 chest patch up to 90 days Feasible ≠ effective 📉❌ #HeartFailure #DigitalHealth @JACCJournals
4
8
1
21
1,464
🫀 Heart failure contributes to ~1 in 7 US deaths (457K/year) 💵 NIH $ per death: 
🧬 HIV ~$717K
🧠 Alzheimer's ~$31K
🎗️ Cancer ~$13K
🫁 COPD ~$824
❤️‍🩹 HF ~$440 (est.) HF gets ~1,600× less than HIV per death Fund HF research!!!📢 @HFSA @ACCinTouch @American_Heart
6
29
1,629